Clinical Trial Update: Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update notes that a Chemo4METPANC regimen combining a chemokine inhibitor, immunotherapy, and chemotherapy is currently recruiting for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Chemo4METPANC regimen

Snippet

Sponsor: Gulam Manji | Conditions: Pancreatic Cancer, Adenocarcinoma of the Pancreas | Phase 2 | Status: RECRUITING